Document is current
Any future updates will be listed below
-
Authors
Hernández Fernández, C.P. https://orcid.org/0000-0002-4832-5483
Borrego, L.
Giménez Arnau, A.M.
Sanz Sánchez, T.
Carrascosa Carrillo, J.M.
Zaragoza Ninet, V.
Serra Baldrich, E.
Miquel Miquel, F.J.
Silvestre Salvador, J.F.
Córdoba Guijarro, S.
Sánchez Gilo, A.
Mercader García, P.
Navarro Triviño, F.
Tous Romero, F.
Rodríguez Serna, M.
Melé Ninot, G.
Ruiz González, I.
Gómez de la Fuente, E.
Pastor Nieto, M.A.
Sánchez-Pedreño Guillén, P.
Sánchez Pérez, J.
Pereyra Rodríguez, J.J.
Gatica Ortega, M.E.
González Pérez, R.
García Doval, I.
Gallego Descalzo, M.A.
-
Funding
Funding for this research was provided by:
Agencia Española de Medicamentos y Productos Sanitarios
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: [Translated article] Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) Still be Part of the Baseline Series?
Journal Title: Actas Dermo-Sifiliográficas
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2025.10.016
CrossRef DOI link to the associated document: https://doi.org/10.1016/j.ad.2024.10.063
Content Type: article
Copyright: © 2025 AEDV. Published by Elsevier España, S.L.U.
